May 10, 2023 — A small randomized trial in patients with post-COVID syndromehas found that hyperbaric oxygen therapy promotes restoration of the heart’s ability to contract properly. The research is presented at EACVI 2023, a scientific congress of the European Society of Cardiology (ESC).1 

May 10, 2023 — A new study has shown that women are underrepresented in late-breaking cardiovascular clinical trials (LBCT) presented at national meetings.

The AIMed Global Summit will be held June 4-7, 2023, at the San Diego Convention Center, featuring a comprehensive agenda of key leaders and wide-ranging sessions on artificial intelligence (AI), its application, opportunities and implications on healthcare.

May 10, 2023 — The AiMed Global Summit will be held June 4-7, 2023, in San Diego, Calif, and program details offered include a comprehensive agenda of key leaders on artificial intelligence (AI) and its application and implications on healthcare. The event will offer six high-value tracks, 200+ speakers, a dozen keynotes, pre and post summit partner events over three days, offering attendees a chance to gain insights into the latest use cases, perspective and approaches in AI medicine.

May 9, 2023 — Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of structural valve deterioration (SVD) in bioprosthetic aortic valves with the company's innovative RESILIA tissue.

May 9, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the American College of Cardiology (ACC), a first edition of a framework for the CADScor System.

May 8, 2023 — An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves freedom from arrhythmias in patients with persistent atrial fibrillation compared to pulmonary vein isolation (PVI) alone, according to late breaking science presented at EHRA 2023, the annual congress of the European Heart Rhythm Association (EHRA) – a branch of the

May 8, 2023 — Researchers of the Cellular and Molecular Neurobiology (CMN) Research Group at the Germans Trias i Pujol Institute (IGTP) have developed and established a novel, reproducible and minimally invasive stroke model in pigs through an endovascular approach.

May 8, 2023 — Ucardia, a cardiac conditioning software developer, announced today that it has reached an agreement to acquire Phas3, a pioneer in home-based cardiac rehab and fellow industry leader. This acquisition will result in a comprehensive, market-leading solution for providers, payers, and consumers, covering all facets of cardiac rehabilitation, conditioning, and remote monitoring for patients affected by cardiovascular disease (CVD). 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now